Update on Tick-borne Disease in the United States
Enduring Material
Online Course
February 27, 2013 - February 27, 2016
- Course Description
- Registration Information
Program (Course) Description
The one-hour, online, enduring material activity is designed to teach physicians the epidemiology of major tick-borne diseases in Texas and throughout the United States as well as acquire the skills needed to identify the signs and symptoms needed to perform the appropriate diagnostic testing and treatment of major tick-borne diseases in the United States.
Who Should Attend?
This activity is designed for physicians, nurses, pharmacists and administrators.
Learning Objectives
Upon completion of this activity the participants will be able to:
- To learn the epidemiology of major tick-borne diseases in the United States and specifically in Texas
- To learn clinical signs and symptoms, appropriate diagnostic testing, and treatment of major tick-borne diseases in the United States
Physician Participation
Upon completion of viewing the one hour online presentation, please follow the instructions at the end of the presentation to complete the evaluation. Upon completion of the evaluation, an option to print the certificate will be provided.
Program Registration Information
| Registration Fees | |
| UTHSCSA Faculty | $25.00 |
| Others | $35.00 |
REGISTER NOW
Continuing Medical Education Credit - Accreditation Statement
UT Health Science Center San Antonio School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release date: February 27, 2013 Credits expire: February 27, 2016
Credit may be obtained upon successful completion of the activity evaluation.
Contact
Continuing Medical Education Office
Email: cme@uthscsa.edu
Phone: 1 (866) 601-4448 or (210)567-4491
Hardware/Software Requirements
- Microsoft® Windows XP, Windows 2003,Windows Vista®, or Windows 7
- Microsoft Internet Explorer® 6.0 SP1 or later, Firefox® 2.0 or later, or Google Chrome 1.0
- Windows Media® Player 9.0 or later
- Broadband Internet connection (256 Kbps & above)
- Apple® Mac® OS X 10.4.8 or later
- Apple Safari™ 2.0.4 or later or Firefox 2.0 or later
- Microsoft Silverlight® 2.0 or later
- Broadband Internet connection (256 Kbps & above)
Faculty/Speaker:
Greg M. Anstead, MD, PhD
Division of Infectious Diseases
Department of Medicine
Financial Disclosure: Dr. Anstead, MD, PhD, has no relevant financial relationships with commercial interest to disclose.
Course Director/Content Reviewer/Planners:
Jan E. Patterson, MD, MS, Content Reviewer
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality and Lifelong Learning
Director, Center for Patient Safety and Health Policy
Financial Disclosure: Dr. Patterson has disclosed that she is a consultant/advisor for Rib-X Pharmaceuticals, Inc as well as an investigator for the UT System and IHI. Her spouse, Dr. Thomas Patterson is a consultant/advisor for Basilea, Merck, Pfizer, and Toyoma as well as an investigator for Astellas, Basilea, Merck, and Pfizer.
Leticia Z. Bresnahan, MBA
Senior Project Coordinator
Center for Patient Safety & Health Policy
Financial Disclosure: Ms Bresnahan has no relevant financial relationships with commercial interest to disclose.